Institute for Cancer Genetics

Displaying 151 - 176 of 176CSV
McQuillan, N., Tazhibi, M., Wei, H.-J., Pouliopoulos, A., Bendau, E., Carrion, A. W., Berg, A., Kokossis, D., Zhang, X., Zhang, Z., Englander, Z., Yoh, N., Jan, C.-I., Gartrell, R. D., Garvin, J., Szalontay, L., Konofagou, E., Zacharoulis, S., & Wu, C.-C. (2022). MODL-25. Radiation and focused ultrasound–mediated blood–brain barrier opening for DMG: safety and feasibility of combinatorial therapy. Neuro-Oncology, 24(Supplement_1), i174–i174. https://doi.org/10.1093/neuonc/noac079.648
Publication Date
Xia, Z., Kon, N., Gu, A. P., Tavana, O., & Gu, W. (2022). Deciphering the acetylation code of p53 in transcription regulation and tumor suppression. Oncogene, 41(22), 3039–3050. https://doi.org/10.1038/s41388-022-02331-9
Publication Date
Antoszewski, M., Fournier, N., Ruiz Buendía, G. A., Lourenco, J., Liu, Y., Sugrue, T., Dubey, C., Nkosi, M., Pritchard, C. E. J., Huijbers, I. J., Segat, G. C., Alonso-Moreno, S., Serracanta, E., Belver, L., Ferrando, A. A., Ciriello, G., Weng, A. P., Koch, U., & Radtke, F. (2022). Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL. Blood, 139(16), 2483–2498. https://doi.org/10.1182/blood.2021012077
Publication Date
Columbia Affiliation
Cortes, J. R., Filip, I., Albero, R., Patiño-Galindo, J. A., Quinn, S. A., Lin, W.-H. W., Laurent, A. P., Shih, B. B., Brown, J. A., Cooke, A. J., Mackey, A., Einson, J., Zairis, S., Rivas-Delgado, A., Laginestra, M. A., Pileri, S., Campo, E., Bhagat, G., Ferrando, A. A., … Palomero, T. (2022). Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma. Cell Reports, 39(3), 110695. https://doi.org/10.1016/j.celrep.2022.110695
Publication Date
Biswas, A. K., Han, S., Tai, Y., Ma, W., Coker, C., Quinn, S. A., Shakri, A. R., Zhong, T. J., Scholze, H., Lagos, G. G., Mela, A., Manova-Todorova, K., de Stanchina, E., Ferrando, A. A., Mendelsohn, C., Canoll, P., Yu, H. A., Paik, P. K., Saqi, A., … Acharyya, S. (2022). Targeting S100A9–ALDH1A1–Retinoic Acid Signaling to Suppress Brain Relapse inEGFR-Mutant Lung Cancer. Cancer Discovery, 12(4), 1002–1021. https://doi.org/10.1158/2159-8290.cd-21-0910
Publication Date
Zhang, P., Gao, K., Zhang, L., Sun, H., Zhao, X., Liu, Y., Lv, Z., Shi, Q., Chen, Y., Jiao, D., Li, Y., Gu, W., & Wang, C. (2021). CRL2-KLHDC3 E3 ubiquitin ligase complex suppresses ferroptosis through promoting p14ARF degradation. Cell Death & Differentiation, 29(4), 758–771. https://doi.org/10.1038/s41418-021-00890-0
Publication Date
Rashkovan, M., Albero, R., Gianni, F., Perez-Duran, P., Miller, H. I., Mackey, A. L., Paietta, E. M., Tallman, M. S., Rowe, J. M., Litzow, M. R., Wiernik, P. H., Luger, S., Sulis, M. L., Soni, R. K., & Ferrando, A. A. (2022). Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic Leukemia. Cancer Discovery, 12(3), 856–871. https://doi.org/10.1158/2159-8290.cd-21-0551
Publication Date
Evrin, C., Serra‐Cardona, A., Duan, S., Mukherjee, P. P., Zhang, Z., & Labib, K. P. M. (2022). Spt5 histone binding activity preserves chromatin during transcription by RNA polymerase II. The EMBO Journal, 41(5). Portico. https://doi.org/10.15252/embj.2021109783
Publication Date
Vilarrasa-Blasi, R., Verdaguer-Dot, N., Belver, L., Soler-Vila, P., Beekman, R., Chapaprieta, V., Kulis, M., Queirós, A. C., Parra, M., Calasanz, M. J., Agirre, X., Prosper, F., Beà, S., Colomer, D., Marti-Renom, M. A., Ferrando, A., Campo, E., & Martin-Subero, J. I. (2021). Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma. Leukemia, 36(2), 583–587. https://doi.org/10.1038/s41375-021-01389-w
Publication Date
Columbia Affiliation
Liu, Y., & Gu, W. (2022). p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death & Differentiation, 29(5), 895–910. https://doi.org/10.1038/s41418-022-00943-y
Publication Date
Chen, V., Bo, C., & Gu, W. (2021). The roads to ferroptosis under homeostatic versus pathological conditions. Molecular & Cellular Oncology, 8(5). https://doi.org/10.1080/23723556.2021.1970477
Publication Date

van der Zwet, J. C. G., Buijs-Gladdines, J. G. C. A. M., Cordo', V., Debets, D. O., Smits, W. K., Chen, Z., Dylus, J., Zaman, G. J. R., Altelaar, M., Oshima, K., Bornhauser, B., Bourquin, J. P., Cools, J., Ferrando, A. A., Vormoor, J., Pieters, R., Vormoor, B., & Meijerink, J. P. P. (2021). MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance. Leukemia, 35(12), 3394–3405. https://doi.org/10.1038/s41375-021-01291-5

Publication Date
Columbia Affiliation
Chen, A. X., Gartrell, R. D., Zhao, J., Upadhyayula, P. S., Zhao, W., Yuan, J., Minns, H. E., Dovas, A., Bruce, J. N., Lasorella, A., Iavarone, A., Canoll, P., Sims, P. A., & Rabadan, R. (2021). Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker. Genome Medicine, 13(1). https://doi.org/10.1186/s13073-021-00906-x
Publication Date
Chen, D., Chu, B., Yang, X., Liu, Z., Jin, Y., Kon, N., Rabadan, R., Jiang, X., Stockwell, B. R., & Gu, W. (2021). iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-23902-6
Publication Date
Wojnarowicz, P. M., Escolano, M. G., Huang, Y.-H., Desai, B., Chin, Y., Shah, R., Xu, S., Yadav, S., Yaklichkin, S., Ouerfelli, O., Soni, R. K., Philip, J., Montrose, D. C., Healey, J. H., Rajasekhar, V. K., Garland, W. A., Ratiu, J., Zhuang, Y., Norton, L., … Benezra, R. (2021). Anti-tumor effects of an ID antagonist with no observed acquired resistance. Npj Breast Cancer, 7(1). https://doi.org/10.1038/s41523-021-00266-0
Publication Date
Shaw, T. I., Dong, L., Tian, L., Qian, C., Liu, Y., Ju, B., High, A., Kavdia, K., Pagala, V. R., Shaner, B., Pei, D., Easton, J., Janke, L. J., Porter, S. N., Ma, X., Cheng, C., Pruett-Miller, S. M., Choi, J., Yu, J., … Zhang, J. (2021). Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL). Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-84647-2
Publication Date
Cortes, J. R., Patrone, C. C., Quinn, S. A., Gu, Y., Sanchez-Martin, M., Mackey, A., Cooke, A. J., Shih, B. B., Laurent, A. P., Trager, M. H., Ferrando, A. A., Geskin, L. J., & Palomero, T. (2021). Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology, 141(12), 2908-2920.e7. https://doi.org/10.1016/j.jid.2021.04.023
Publication Date
Prakash, R., Sandoval, T., Morati, F., Zagelbaum, J. A., Lim, P.-X., White, T., Taylor, B., Wang, R., Desclos, E. C. B., Sullivan, M. R., Rein, H. L., Bernstein, K. A., Krawczyk, P. M., Gautier, J., Modesti, M., Vanoli, F., & Jasin, M. (2021). Distinct pathways of homologous recombination controlled by the SWS1–SWSAP1–SPIDR complex. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-24205-6
Publication Date